The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
The renin–angiotensin system and cancer: old dog, new tricks
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MicroRNA-155 Regulates Human Angiotensin II Type 1 Receptor Expression in Fibroblasts
Martin, M. M., Lee, E. J., Buckenberger, J. A., Schmittgen, T. D., & Elton, T. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601496200 · Cited by 225
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Tiret, L., Rigat, B. A., Visvikis‐Siest, S., Breda, C., Corvol, P. L., Cambien, F., & Soubrier, F. (1992) · Europe PMC (PubMed Central) · Cited by 1,174
Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710052104 · Cited by 1,075
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., & Bernstein, K. E. (1995) · Nature · doi:10.1038/375247a0 · Cited by 745
Singh, K. D., & Karnik, S. S. (2020) · GPCRs · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 704
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
The renin-angiotensin-aldosterone system: Past, present and future
Vecsei, P., Hackenthal, E., & Ganten, D. (1978) · Klinische Wochenschrift · doi:10.1007/bf01477448 · Cited by 604
Role of p47 phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II
Landmesser, U., Cai, H., Dikalov, S., McCann, L., Hwang, J., Jo, H., Holland, S. M., & Harrison, D. G. (2002) · Hypertension · doi:10.1161/01.hyp.0000032100.23772.98 · Cited by 577
Ushio-Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., & Griendling, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22699 · Cited by 558
p22phox mRNA Expression and NADPH Oxidase Activity Are Increased in Aortas From Hypertensive Rats
Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q., Taylor, W. R., Harrison, D. G., de Leon, H., Wilcox, J. N., & Griendling, K. K. (1997) · Circulation Research · doi:10.1161/01.res.80.1.45 · Cited by 553
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
Lever, A. F., Hole, D. J., Gillis, C. R., McCallum, I. R., McInnes, G. T., MacKinnon, P. L., Meredith, P. A., Murray, L. S., Reid, J. L., & Robertson, J. W. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03228-0 · Cited by 545
Hunyady, L., & Catt, K. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0536 · Cited by 541
Huang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Young, D., Waitches, G., Birchmeier, C., Fasano, O., & Wigler, M. (1986) · Cell · doi:10.1016/0092-8674(86)90785-3 · Cited by 481
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
Sipahi, I., Debanne, S. M., Rowland, D. Y., Simon, D. I., & Fang, J. C. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70106-6 · Cited by 481
Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase
Albiston, A. L., McDowall, S. G., Matsacos, D., Sim, P., Clune, E., Mustafa, T., Lee, J., Mendelsohn, F. A. O., Simpson, R. J., Connolly, L. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100512200 · Cited by 461
Angiotensin receptors: a new role in cancer?
Deshayes, F., & Nahmias, C. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.07.009 · Cited by 437
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 430
Estrogen Modulates AT 1 Receptor Gene Expression In Vitro and In Vivo
Nickenig, G., Bäumer, A. T., Grohè, C., Kahlert, S., Strehlow, K., Rosenkranz, S., Stäblein, A., Beckers, F., Smits, J. F. M., Daemen, M. J. A. P., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2197 · Cited by 409
Building a new conceptual framework for receptor heteromers
Ferré, S., Baler, R., Bouvier, M., Caron, M. G., Devi, L. A., Durroux, T., Fuxe, K., George, S. R., Javitch, J. A., Lohse, M. J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio0309-131 · Cited by 394
NADPH oxidases and angiotensin II receptor signaling
Garrido, A. M., & Griendling, K. K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.003 · Cited by 386
Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms
Pagé, E. L., Robitaille, G. A., Pouysségur, J., & Richard, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209114200 · Cited by 385
Sethupathy, P., Borel, C., Gagnebin, M., Grant, G. R., Deutsch, S., Elton, T. S., Hatzigeorgiou, A. G., & Antonarakis, S. E. (2007) · The American Journal of Human Genetics · doi:10.1086/519979 · Cited by 361
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth
Egami, K., Murohara, T., Shimada, T., Sasaki, K.-I., Shintani, S., Sugaya, T., Ishii, M., Akagi, T., Ikeda, H., Matsuishi, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16645 · Cited by 345
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Bader, M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105610 · Cited by 345
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Gschwind, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg231 · Cited by 342
ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors
Ohtsu, H., Dempsey, P. J., & Eguchi, S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00620.2005 · Cited by 338
Ruiz-Ortega, M., Lorenzo, O., Rupérez, M., König, S., Wittig, B., & Egido, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1266 · Cited by 331
Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor Agonist
Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A. K., Wu, X., Johansson, B., Holm, M., Botoros, M., Karlén, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049715t · Cited by 330
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
The renin-angiotensin system and malignancy
Ager, E. I., Neo, J., & Christophi, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn171 · Cited by 295
Estrogen regulation of angiotensin-converting enzyme mRNA
Gallagher, P. E., Li, P., Lenhart, J. R., Chappell, M. C., & Brosnihan, K. B. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.323 · Cited by 290
β-arrestins: traffic cops of cell signaling
Lefkowitz, R. J., & Whalen, E. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.01.001 · Cited by 282
The AT2 receptor—A matter of love and hate
Steckelings, U. M., Kaschina, E., & Unger, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.010 · Cited by 257
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice
Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200403000-00016 · Cited by 244
Suganuma, T., Ino, K., Shibata, K., Kajiyama, H., Nagasaka, T., Mizutani, S., & Kikkawa, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1946 · Cited by 237
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
Fujita, M., Hayashi, I., Yamashina, S., Itoman, M., & Majima, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00496-5 · Cited by 233
Luque, M., Martin, P., Martell, N., Fernandez, C., Brosnihan, K. B., & Ferrario, C. M. (1996) · Journal of Hypertension · doi:10.1097/00004872-199606000-00017 · Cited by 230
The Biology of the (Pro)Renin Receptor
Nguyen, G., & Muller, D. N. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030300 · Cited by 220
Gschwind, A., Prenzel, N., & Ullrich, A. (2002) · PubMed · Cited by 220
Yoshiji, H., Kuriyama, S., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., & Fukui, H. (2001) · PubMed · Cited by 211
Touyz, R. M., Yao, G., Viel, E., Amiri, F., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00015 · Cited by 197
Zambidis, E. T., Soon Park, T., Yu, W., Tam, A., Levine, M., Yuan, X., Pryzhkova, M., & Péault, B. (2008) · Blood · doi:10.1182/blood-2008-03-144766 · Cited by 196
Nickenig, G., & Harrison, D. G. (2002) · Circulation · doi:10.1161/hc0402.102619 · Cited by 196
Uemura, H., Ishiguro, H., Nakaigawa, N., Nagashima, Y., Miyoshi, Y., Fujinami, K., Sakaguchi, A., & Kubota, Y. (2003) · PubMed · Cited by 188
Angiotensin II and atherosclerosis
Weiss, D., Sorescu, D., & Taylor, W. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01539-9 · Cited by 180
Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
Le Noble, F. A. C., Hekking, J. W. M., Van Straaten, H. W. M., Slaaf, D. W., & Struyker Boudier, H. A. J. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90552-2 · Cited by 179
Rhodes, D. R., Ateeq, B., Cao, Q., Tomlins, S. A., Mehra, R., Laxman, B., Kalyana-Sundaram, S., Lonigro, R. J., Helgeson, B. E., Bhojani, M. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900351106 · Cited by 172
Thomas, W. G., Brandenburger, Y., Autelitano, D. J., Pham, T., Qian, H., & Hannan, R. D. (2002) · Circulation Research · doi:10.1161/hh0202.104109 · Cited by 172
Self-citationInhibition of human lung cancer cell growth by angiotensin-(1-7)
Gallagher, P. E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh236 · Cited by 165
Fujita, M., Hayashi, I., Yamashina, S., Fukamizu, A., Itoman, M., & Majima, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh324 · Cited by 165
Wilop, S., von Hobe, S., Crysandt, M., Esser, A., Osieka, R., & Jost, E. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0587-3 · Cited by 163
Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada)
Perron, L., Bairati, I., Harel, F., & Meyer, F. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036152.58271.5e · Cited by 160
Miyajima, A., Kosaka, T., Asano, T., Asano, T., Seta, K., Kawai, T., & Hayakawa, M. (2002) · PubMed · Cited by 158
Fujimoto, Y., Sasaki, T., Tsuchida, A., & Chayama, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02377-8 · Cited by 147
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma
Juillerat‐Jeanneret, L., Célérier, J., Bernasconi, C. C., Nguyen, G., Wostl, W., Maerki, H. P., Janzer, R.-C., Corvol, P. L., & Gasc, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601646 · Cited by 146
Koh, W., Yuan, J., Sun, C., Berg, D. V. D., Seow, A., Lee, H.-P., & Yu, M. C. (2003) · PubMed · Cited by 144
Angiotensinogen and Its Cleaved Derivatives Inhibit Angiogenesis
Célérier, J., Cruz, A., Lamandé, N., Gasc, J., & Corvol, P. L. (2002) · Hypertension · doi:10.1161/hy0202.103441 · Cited by 141
The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor
Porrello, E. R. (2009) · Frontiers in bioscience · doi:10.2741/3289 · Cited by 138
Menon, J., Soto‐Pantoja, D. R., Callahan, M. F., Cline, J. M., Ferrario, C. M., Tallant, E. A., & Gallagher, P. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3614 · Cited by 138
Soto‐Pantoja, D. R., Menon, J., Gallagher, P. E., & Tallant, E. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0161 · Cited by 138
van der Knaap, R., Siemes, C., Coebergh, J. W. W., van Duijn, C. M., Albert Hofman, D., & Stricker, B. H. C. (2008) · Cancer · doi:10.1002/cncr.23215 · Cited by 134
Greco, S., Muscella, A., Elia, M. G., Salvatore, P., Storelli, C., Mazzotta, A., Manca, C., & Marsigliante, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10313 · Cited by 131
Li, C. I., Malone, K. E., Weiss, N. S., Boudreau, D. M., Cushing‐Haugen, K. L., & Daling, J. R. (2003) · Cancer · doi:10.1002/cncr.11663 · Cited by 130
Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma
Hii, S.-I., Nicol, D. L., Gotley, D. C., Thompson, L. C., Green, M. K., & Jonsson, J. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.145 · Cited by 129
Neo, J. H., Malcontenti‐Wilson, C., Muralidharan, V., & Christophi, C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04797.x · Cited by 127
le Noble, F. A. C., Schreurs, N. H., van Straaten, H. W. M., Slaaf, D. W., Smits, J. F. M., Rogg, H., & Struijker-Boudier, H. A. J. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.2.r460 · Cited by 127
Taniyama, Y., Ushio‐Fukai, M., Hitomi, H., Ročić, P., Kingsley, M. J., Pfahnl, C. L., Weber, D. S., Alexander, R. W., & Griendling, K. K. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00439.2003 · Cited by 126
Angiotensin II signaling pathways mediated by tyrosine kinases
Yin, G., Chen, Y., & Berk, B. C. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00300-x · Cited by 125
Ino, K., Shibata, K., Kajiyama, H., Yamamoto, E., Nagasaka, T., Nawa, A., Nomura, S., & Kikkawa, F. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602961 · Cited by 125
Arora, P., Cuevas, B. D., Russo, A., Johnson, G. L., & Trejo, J. (2008) · Oncogene · doi:10.1038/onc.2008.84 · Cited by 124
Arrieta, O. G., Guevara, P., Escobar, E., García-Navarrete, R., Pineda, B., & Sotelo, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602483 · Cited by 120
Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer
Meier, C. R., Derby, L. E., Jick, S. S., & Jick, H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.3.349 · Cited by 116
Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II
Papp, M., Li, X., Zhuang, J., Wang, R., & Uhal, B. D. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00103.2001 · Cited by 115
Association between captopril, other antihypertensive drugs and risk of prostate cancer
Ronquist, G., Rodríguez, L. A. G., Ruigómez, A., Johansson, S., Wallander, M.-A. A., Frithz, G., & Svärdsudd, K. (2003) · The Prostate · doi:10.1002/pros.10294 · Cited by 113
Arafat, H. A., Gong, Q., Chipitsyna, G. I., Rizvi, A., Saa, C. T., & Yeo, C. J. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.01.067 · Cited by 111
T lymphocytes: a role in hypertension?
Schiffrin, E. L. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283360a2e · Cited by 110
Touyz, R. M., Cruzado, M., Tabet, F., Yao, G., Salomon, S., & Schiffrin, E. L. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-164 · Cited by 110
Christian, J. B., Lapane, K. L., Hume, A., Eaton, C. B., & Weinstock, M. A. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn262 · Cited by 110
Ermert, L., Dierkes, C., & Ermert, M. (2003) · PubMed · Cited by 110
Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.
Timmermans, P. B. M. W. M. (1999) · Hypertension Research · doi:10.1291/hypres.22.147 · Cited by 106
Cancer, inflammation and the AT1 and AT2 receptors.
Smith, G. R., & Missailidis, S. (2004) · Journal of Inflammation · doi:10.1186/1476-9255-1-3 · Cited by 104
Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone
Petty, W. J., Miller, A. A., McCoy, T. P., Gallagher, P. E., Tallant, E. A., & Torti, F. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1957 · Cited by 102
Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo
Li, X., Zhang, H., Soledad‐Conrad, V., Zhuang, J., & Uhal, B. D. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00273.2002 · Cited by 100
Type 1 angiotensin receptor pharmacology: Signaling beyond G proteins
Oro, C., Qian, H., & Thomas, W. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.10.001 · Cited by 99
Self-citationKrishnamurthi, K., Verbalis, J. G., Zheng, W. H., Wu, Z., Clerch, L. B., & Sandberg, K. L. (1999) · Endocrinology · doi:10.1210/endo.140.11.7242 · Cited by 97
Brosnihan, K. B., Hodgin, J. B., Smithies, O., Maeda, N., & Gallagher, P. E. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041806 · Cited by 96
Ayoub, M. A., & Pfleger, K. D. G. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.012 · Cited by 95
Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer
Kosaka, T., Miyajima, A., Takayama, E., Kikuchi, E., Nakashima, J., Ohigashi, T., Asano, T., Sakamoto, M., Okita, H., Murai, M., et al. (2006) · The Prostate · doi:10.1002/pros.20486 · Cited by 95
Captopril as a Potential Inhibitor of Lung Tumor Growth and Metastasis
Attoub, S., Gaben, A., Al‐Salam, S., Sultan, M. A. H. A., John, A., Nicholls, M. G., Mešter, J., & Petroianu, G. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1414.011 · Cited by 95
Angiotensin II Signal Transduction Through Small GTP-Binding Proteins
Ohtsu, H., Suzuki, H., NAKASHIMA, H., Dhobale, S., Frank, G. D., Motley, E. D., & Eguchi, S. (2006) · Hypertension · doi:10.1161/01.hyp.0000237975.90870.eb · Cited by 94
Röcken, C., Lendeckel, U., Dierkes, J., Westphal, S., Carl‐McGrath, S., Peters, B., Krüger, S., Malfertheiner, P., Roessner, A., & Ebert, M. P. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1922 · Cited by 93
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
Rivera, E., Arrieta, O. G., Guevara, P., Duarte‐Rojo, A., & Sotelo, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2102 · Cited by 89
Estrogen Regulates Adrenal Angiotensin AT 1 Receptors by Modulating AT 1 Receptor Translation
Wu, Z., Maric, C., Roesch, D. M., Zheng, W., Verbalis, J. G., & Sandberg, K. L. (2003) · Endocrinology · doi:10.1210/en.2003-0015 · Cited by 88
Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
Herr, D., Rodewald, M., Fraser, H. M., Hack, G., Konrad, R., Kreienberg, R., & Wulff, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.02.019 · Cited by 88
武田, 光., & Kondo, S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64119-3 · Cited by 86
Anandanadesan, R., Gong, Q., Chipitsyna, G. I., Witkiewicz, A., Yeo, C. J., & Arafat, H. A. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0403-9 · Cited by 85
Not just angiotensinases: new roles for the angiotensin-converting enzymes
Lambert, D., Clarke, N. E., & Turner, A. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0152-x · Cited by 84
Paepe, B. D., Verstraeten, V. L. R. M., Potter, C. R. D., Vakaet, L., & Bullock, G. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100313 · Cited by 84
Genetics of the human renin angiotensin system
Jeunemaître, X. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0344-0 · Cited by 82
Medeiros, R., Vasconcelos, A., Costa, S., Pinto, D., Lobo, F., Morais, A., Oliveira, J., & Lopes, C. (2004) · The Journal of Pathology · doi:10.1002/path.1529 · Cited by 82
Shah, B. H., Yeşilkaya, A., Olivares-Reyes, J. A., Chen, H., Hunyady, L., & Catt, K. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0476 · Cited by 79
Haiman, C. A., Henderson, S. O., Bretsky, P. M., Kolonel, L. N., & Henderson, B. E. (2003) · PubMed · Cited by 79
The role of the renin-angiotensin system in aortic aneurysmal diseases
Lu, H. S., Rateri, D. L., Cassis, L. A., & Daugherty, A. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0020-3 · Cited by 77
Angiotensin II type 1 receptor expression in human breast tissues
Inwang, E., Puddefoot, J. R., Brown, C., Goode, A. W., Marsigliante, S., Ho, M. M., Payne, J., & Vinson, G. P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.217 · Cited by 76
Zhao, Y., Chen, X., Cai, L., Yang, Y., Sui, G., & Fu, S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22209 · Cited by 75
Angiotensinogen Delays Angiogenesis and Tumor Growth of Hepatocarcinoma in Transgenic Mice
Vincent, F., Bonnin, P., Clemessy, M., Contrerès, J.-O., Lamandé, N., Gasc, J., Vilar, J., Hainaud, P., Tobelem, G., Corvol, P. L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2484 · Cited by 75
Kinoshita (2009) · International Journal of Oncology · doi:10.3892/ijo_00000287 · Cited by 73
Doi, C., Egashira, N., Kawabata, A., Maurya, D. K., Ohta, N., Uppalapati, D., Ayuzawa, R., Pickel, L., Isayama, Y., Troyer, D. L., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-67 · Cited by 72
Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo
Heringer‐Walther, S., Eckert, K., Schumacher, S.-M., Uharek, L., Wulf-Goldenberg, A., Gembardt, F., Fichtner, I., Schultheiß, H., Rodgers, K. E., & Walther, T. (2009) · Haematologica · doi:10.3324/haematol.2008.000034 · Cited by 72
Angiotensin type 2 receptor–mediated apoptosis of human prostate cancer cells
Li, H., Qi, Y., Li, C.-Y., Braseth, L. N., Gao, Y., Shabashvili, A. E., Katovich, M. J., & Sumners, C. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0237 · Cited by 72
Watanabe, Y., Shibata, K., Kikkawa, F., Kajiyama, H., Ino, K., Hattori, A., Tsujimoto, M., & Mizutani, S. (2003) · PubMed · Cited by 71
Walsh, D. A., Hu, D., Wharton, J., Catravas, J. D., Blake, D. R., & Fan, T. D. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701062 · Cited by 69
Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer
Uemura, H., Hasumi, H., Kawahara, T., Sugiura, S., Miyoshi, Y., Nakaigawa, N., Teranishi, J., Noguchi, K., Ishiguro, H., & Kubota, Y. (2005) · International Journal of Clinical Oncology · doi:10.1007/s10147-005-0520-y · Cited by 67
Rudnicki, M., & Mayer, G. J. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.3.463 · Cited by 66
Koh, W.-P., Yuan, J.-M., Berg, D. V. D., Lee, H.-P., & Yu, M. C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh309 · Cited by 64
Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Breast Cancer Risk
Ladd, A. M. G., Vásquez, A. A., Sayed‐Tabatabaei, F. A., Coebergh, J. W. W., Albert Hofman, D., Njajou, O. T., Stricker, B. H. C., & van Duijn, C. M. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0045 · Cited by 64
The (pro)renin receptor in health and disease
Nguyen, G. (2010) · Annals of Medicine · doi:10.3109/07853890903321567 · Cited by 63
Amaya, K., Ohta, T., Kitagawa, H., Kayahara, M., Takamura, H., Fujimura, T., Nishimura, G., Shimizu, K., & Miwa, K. (2004) · PubMed · Cited by 62
Genomic profiling of 766 cancer‐related genes in archived esophageal normal and carcinoma tissues
Chen, J., Guo, L., Peiffer, D. A., Zhou, L., Chan, O. T. M., Bibikova, M. V., Wickham‐Garcia, E., Lu, S., Zhan, Q., Wang‐Rodriguez, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23397 · Cited by 62
SHAH, B., & Catt, K. J. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.06.011 · Cited by 61
Pickel, L., Matsuzuka, T., Doi, C., Ayuzawa, R., Maurya, D. K., Xie, S., Berkland, C. J., & Tamura, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.4.10643 · Cited by 59
Unger, T., & Dahlöf, B. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309347792 · Cited by 59
Molecular determinants of angiotensin II type 1 receptor functional selectivity
Aplin, M., Bonde, M. M., & Hansen, J. L. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.123 · Cited by 58
Otake, A. H., Mattar, A. L., Freitas, H., Machado, C. M. L., Nonogaki, S., Fujihara, C. K., Zatz, R., & Chammas, R. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1136-0 · Cited by 58
PKC‐ζ is required for angiotensin II‐induced activation of ERK and synthesis of C‐FOS in MCF‐7 cells
Muscella, A., Greco, S., Elia, M. G., Storelli, C., & Marsigliante, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10336 · Cited by 57
A role for the renin-angiotensin system in hematopoiesis
Park, T. S., & Zambidis, E. T. (2009) · Haematologica · doi:10.3324/haematol.2009.006965 · Cited by 57
Activation of invasiveness of cervical carcinoma cells by angiotensin II
Kikkawa, F., Mizuno, M., Shibata, K., Kajiyama, H., Morita, T., Ino, K., Nomura, S., & Mizutani, S. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.12.013 · Cited by 53
Corrêa, S. A. A., de Noronha, S. M. R., Nogueira-de-Souza, N. C., de Carvalho, C. V., Costa, A. M. M., Linhares, J. J., Gomes, M. T. V., & da Silva, I. D. C. G. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309102317 · Cited by 53
Ebert, M. P., Lendeckel, U., Westphal, S., Dierkes, J., Glas, J., Folwaczny, C., Roessner, A., Stolte, M., Malfertheiner, P., & Röcken, C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0411 · Cited by 51
TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease
Shah, B. H., & Catt, K. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.03.010 · Cited by 49
Yoshiji, H. (2009) · Oncology Reports · doi:10.3892/or_00000445 · Cited by 49
Angiotensin II Induces Oxidative Stress in Prostate Cancer
Uemura, H., Ishiguro, H., Ishiguro, Y., Hoshino, K., Takahashi, S., & Kubota, Y. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0289 · Cited by 48
Freitas-Silva, M., Pereira, D., Coelho, C., Bicho, M., Lopes, C., & Medeiros, R. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.03.020 · Cited by 48
Sugimoto, M., Furuta, T., Shirai, N., Ikuma, M., Sugimura, H., & Hishida, A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0339 · Cited by 48
Smith, N. J., Chan, H., Osborne, J. E., Thomas, W. G., & Hannan, R. D. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4244-3 · Cited by 47
Self-citationLyngsø, C., Erikstrup, N., & Hansen, J. L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.018 · Cited by 47
Therapeutic targeting of insulin-regulated aminopeptidase: Heads and tails?
Albiston, A. L., Peck, G. R., Yeatman, H. R., Fernando, R. N., Ye, S., & Chai, S. Y. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.07.006 · Cited by 46
The angiotensin AT2 receptor in inflammation
Rompe, F., Unger, T., & Steckelings, U. M. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.2.1475901 · Cited by 45
Kohlstedt, K., Gershome, C., Friedrich, M., Müller‐Esterl, W., Alhenc‐Gelas, F., Busse, R., & Fleming, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020636 · Cited by 45
Itabashi, H., Maesawa, C., Oikawa, H., Kotani, K., Sakurai, E., Kato, K., Komatsu, H., Nitta, H., Kawamura, H., Wakabayashi, G., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00304.x · Cited by 43
Angiotensin-ll-lnduced Angiogenesis in Sponge Implants in Mice
Andrade, S. P., Cardoso, C. C., Machado, R. D. P., & Beraldo, W. T. (2008) · International Journal of Microcirculation · doi:10.1159/000179189 · Cited by 38
Zhou, L., Zhang, R., Yao, W., Wang, J., Qian, A., Qiao, M.-M., Zhang, Y., & Yuan, Y. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.217.123 · Cited by 37
Wang, L., Cai, S., Zhang, C., He, Y.-L., Zhan, W.-H., Wu, H. B. K., & Peng, J. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811010-00012 · Cited by 37
Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis.
Yiğit, B., Bozkurt, N., Narter, F., Yılmaz, H., Yücebaş, E., & İşbir, T. (2007) · PubMed · Cited by 36
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma
Marsigliante, S., Resta, L., Muscella, A., Vinson, G. P., Marzullo, A., & Storelli, C. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04449-7 · Cited by 35
Chehl, N., Gong, Q., Chipitsyna, G. I., Aziz, T., Yeo, C. J., & Arafat, H. A. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-1055-8 · Cited by 32
Ohta, T., Amaya, K., Yi, S., Kitagawa, H., Kayahara, M., Ninomiya, I., Fushida, S., Fujimura, T., Nishimura, G., Shimizu, K., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.3.593 · Cited by 32
Role of renin–angiotensin system in adipose tissue dysfunction
Iwai, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.55 · Cited by 29
Lim, K. T., Cosgrave, N., Hill, A. D. K., & Young, L. S. (2006) · Breast Cancer Research · doi:10.1186/bcr1509 · Cited by 23
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection
Siragy, H. M. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0044-3 · Cited by 22
Cited by
Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031
How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases
Kopp, W. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s216791 · Cited by 660
Murphy, J. E., Wo, J. Y., Ryan, D. P., Clark, J. W., Jiang, W., Yeap, B. Y., Drapek, L. C., Ly, L., Baglini, C. V., Blaszkowsky, L. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0892 · Cited by 522
Scaffolds for Wound Healing Applications
Negut, I., Dorcioman, G., & Grumezescu, V. (2020) · Polymers · doi:10.3390/polym12092010 · Cited by 415
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Pinter, M., & Jain, R. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5616 · Cited by 332
Metadata
- Authors
- George, A. J., Thomas, W. G., & Hannan, R. D.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-22
- Volume
- 10
- Issue
- 11
- Pages
- 745-759
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2094546405
- Cited by
- 525
- References
- 172
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.